课题基金 / 基金详情

RNA EXPRESSION PROFILES OF SIV-SPECIFIC CD8+ T CELLS

RNA EXPRESSION PROFILES OF SIV-SPECIFIC CD8+ T CELLS
SIV 特异性 CD8 T 细胞的 RNA 表达谱
批准号:
8357985
负责人:
NORMAN L LETVIN
金额:
$6.84万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-05-01 至 2012-04-30

项目摘要

项目成果

NORMAN L LETVIN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. Primary support for the subproject and the subproject's principal investigator may have been provided by other sources, including other NIH sources. The Total Cost listed for the subproject likely represents the estimated amount of Center infrastructure utilized by the subproject, not direct funding provided by the NCRR grant to the subproject or subproject staff. It is known that SIV-infected Mamu-A*01+ rhesus macaques develop lower plasma viral loads than Mamu-A*01- monkeys. CD8+ T cells possibly play a role in the control of viremia. To test this hypothesis SIV-specific CD8+ T cells from Mamu-A*01+ (A*02-, B*17-,B*08-) monkeys and Mamu-A*02+ (A*01-, B*17-, B*08-) monkeys are being isolated. Virus-specific CD8+ T cells may be different in Mamu-A*01+ monkeys from those on Mamu-A*02+ monkeys. This difference may be reflected in the RNA transcripts that are present in the virus-specific CD8+ T cells from monkeys with different genotypes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Non-Human Primate Core
  • 批准号:
    8294667
  • 项目类别:
  • 资助金额:
    $171.39万
  • 财政年份:
    2011
  • 负责人:
    NORMAN L LETVIN
  • 依托单位:
MOSAIC VACCINE-ELICITED IMMUNE RESPONSES IN RHESUS MONKEYS
  • 批准号:
    8357984
  • 项目类别:
  • 资助金额:
    $6.84万
  • 财政年份:
    2011
  • 负责人:
    NORMAN L LETVIN
  • 依托单位:
Host Genetics Core
  • 批准号:
    8294660
  • 项目类别:
  • 资助金额:
    $134.08万
  • 财政年份:
    2011
  • 负责人:
    NORMAN L LETVIN
  • 依托单位:
RECOMBINANT BCG CANDIDATE VACCINE IMMUNOGENICITY STUDY
  • 批准号:
    8358015
  • 项目类别:
  • 资助金额:
    $6.84万
  • 财政年份:
    2011
  • 负责人:
    NORMAN L LETVIN
  • 依托单位:
海外基金